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Summary. Sleep patterns of two young female patients 
with congenital dopamine betä-hydroxylase deficiency 
are described. In this orthostatic syndrome central and 
peripheral noradrenergic failure occurs as a result of im- 
paired beta-hydroxylat ion of dopamine. Consequently, 
the levels of dopamine and its metabolites are elevated. 
The relative importance of noradrenaline deficit in the 
face of dopamine excess for sleep-regulatory mecha- 
nisms can be inferred from the sleep pattern of these pa- 
tients. No subjective sleep complaints were reported. 
The sleep patterns showed a high percentage of slow- 
ware sleep in both patients (29% and 34% of sleep 
period time) and a relatively low to normal percentäge 
of REM sleep (18% and 21%). A normal cyclic REM 
sleep pattern was observed. Alpha-delta sleep occurred 
during light sleep (15% and 8%); consequently, the 
amount of stage 2 sleep was reduced. These results indi- 
cate that functional insufficiency of the noradrenergic 
system in two pätients with dopamine beta-hydroxylase 
deficiency is not associated with profound changes in the 
(REM)  sleep pattern. This supports a modulatory or 
permissive role for noradrenal ine in REM sleep mecha- 
nisms. 
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lntroduction 
Numerous attempts have been made to relate the role of 
neurotransmitters,  especially noradrenaline, serotonin, 
dopamine and acetylcholine, to the different stages of 
sleep (for reviews, see [1, 7, 23]). Currently, it is clear 
that a number  of biochemical and neuronal events are 
involved in the induction of different sleep states and 
that no single neurotransmitter is solely responsible for 
one distinct function. 
The role of neurotransmitters in the initiätion and 
maintenance of sleep, as well as the induction of rapid 
eye movement  (REM)  and non-REM (NREM)  sleep, 
have been studied in man primarily by pharmacological 
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methods. Distinct from this pharmacological pproach, 
the syndrome of congenital dopamine beta-hydroxylase 
(DBH)  deficiency, as an experiment of nature, may 
serve to illustrate the relative importance of some of 
these neurotransmitters. 
Sleep characteristics of two patients with selective 
noradrenergic failure as a result of a DBH deficiency, 
both centrally and peripherally, were studied. In this 
syndrome xcessive amounts of dopamine and its meta- 
bolites were found in plasma, urine and cerebrospinal 
fluid (CSF), whereas noradrenaline, adrenaline and 
their metabolites could not be detected. The relative im- 
portance of noradrenaline and dopamine in sleep-wake 
regulatory mechanisms can be inferred from the study of 
the sleep pattern of these patients. 
Patients and methods 
The two female patients have been described in detail elsewhere 
[Il, 13]. They were 31 and 21 years of age. Both patients presented 
with severe orthostatic hypotension, which appeared to be due to 
autonomie failure, since the phase IV in the Valsalva response was 
absent. Autonomie failure was due to selective noradrenergic fail- 
ure as a result of DBH deficiency. The defect eould be demon- 
strated both centrally and peripherally: noradrenaline and adrena- 
line were undetectable in plasma, urine and CSF, but dopamine 
was 7- to 12-fold increased in plasma, 4-fold in urine, and 20-fold 
in CSF. Normetanephrine, metanephrine, 3-methoxy-4-hydroxy- 
phenylethylene glycol (MHPG) and vanillylmandelic acid were not 
detectable in urine and MHPG was also not detectable in CSF, 
which was further evidence for impaired beta-hydroxylation f 
dopamine. Aceumulation of dopamine was also shown by in- 
creased levels of its metabolites; homovanillie acid (HVA) and 3- 
methoxytyramine w re elevated in urine and HVA was also ele- 
vated in CSF. Indeed, DBH activity could not be deteeted in 
plasma or CSF. A summary of the biochemical findings of these 
patients is given in Table 1. 
Cholinergic function (sweating, heart rate, gastric acid produe- 
tion, pupil diameter) was intact. Physiological and pharmacotogi- 
eal manoeuvres to manipulate sympathetie neurotransmitter r -
lease (hypoglycaemia, ganglionic stimulation, tyramine, head-up 
tilting, yohimbine, clonidine) caused changes in dopamine, 
whereas noradrenaline and adrenaline were never detected. These 
data suggest hat in the syndrome of eongenital DBH deficiency 
dopamine rather than noradrenaline is released as the sympathetic 
neurotransmitter, but that the sympathetic neuron is otherwise 
intact [12, 13]. 
Blood pressure. Twenty-four-hour blood pressure profiles were 
recorded in the two patients by means of the Oxford technique, 
Table 1. Biochemical data of two patients with autonomic failure 
due to dopamine beta-hydroxylase d ficiency, as compared with 
other patients with chronic autonomic failure due to various causes 
Tests DBH Chronic Normals 
deficiency autonomic 
failure 
(n = 2) (n = 12) (n = 56) 
Plasmanoradrenaline 0 0.5, 0.1 1.8, 1.0 
(nmol/1) 
Plasma drenaline 0 0.25, 0.19 0.40, 0.30 
(nmol/l) 
Plasma dopamine 3.4, 0.3 0.50, 0.21 0.43, 0.28 
(nmol/1) 
(n = 2) (n = 9) (n = 20) 
Urinary VMA 0 400, 310 1600, 520 
(gmol/mol creatinine) 
Urinary MHPG 0 550,210 1120, 430 
(gmol/mol creatinine) 
Urinary HVA 5400, 200 640,490 2050, 780 
(~tmol/mol creatinine) 
(n = 1) (n = 0) (n = 12) 
Cerebrospinal fluid 0 - 0.6, 0.3 
noradrenaline (nmol/l) 
Cerebrospinal fluid 0 - 0.06, 0.03 
adrenaline (nmol/1) 
Cerebrospinal fluid 1.8 - 0.1, 0.1 
dopamine (nmol/1) 
Cerebrospinal fluid 0 - 55, 18 
MHPG (nmol/1) 
Cerebrospinal fluid 580 - 280,160 
HVA (nmol/1) 
Data were taken from [11, 13]. Indicated are means, SD. DBH = 
Dopamine beta-hydroxylase; VMA = free vanillylmandelic a id; 
MHPG = 3-methoxy-4-hydroxyphenylethylene glycol; HVA = 
homovanillic acid 
which has been described in detail elsewhere [14]. The 24-h blood 
pressure profiles and sleep records were made on separate occa- 
sions. One patient had not taken drugs for her orthostatic hypoten- 
sion for 3 months, whereas in the other patient pindolol (5 mg od) 
was stopped 2weeks before the recordings. 
Sleep recordings and analyses. The sleep recordings were made in 
the clinic: four consecutive recordings of patient 1 and three re- 
cordings of patient 2. Bed-time and rise-time were scheduled for 
each patient to approximate home sleep patterns. 
All night polysomnographic re ordings included two electro- 
oculograms (EOGs), two EEG derivations (C3-A2; C4-A1) and 
submental chin EMG, according to standardized lead placements 
[16], in addition to frontal, temporal and occipital EEG leads 
(F4-C4, C4-P4, P4-O2, F3-C3, C3-P3, P3-O1, T4-C0, C0-T3). 
All signals were amplified and monitored on a 21-channel Siemens 
Elema electroencephalograph. An amplification of 50 gV/cm was 
used in the EEG channels and 100 laV/cm in the EOG channels. 
The time constants for the EOG and EEG recordings were 1.2 s 
and the high frequency cut-off was 70 Hz. For the EMG we used a 
time constant of 0.015 s and a high frequency cut-off of 300 Hz. 
Sleep stages were defined (in 30-s epochs) according to the 
criteria of Rechtschaffen and Kales [16] by two independent re- 
searchers. Sleep parameters were calculated according to the d fi- 
nitions of Williams et al. [24]. Alpha-delta sleep occurred in both 
patients. This pattern consisted of the intrusion of the EEG alpha 
frequency into NREM sleep as weil as of the regular occurrence of
10-20 s of alpha-like activity, alternating with delta bursts. This 
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sleep characteristic was quantified separately by counting the 
number of 30-s epochs with a predominance of alpha-delta sleep 
(i.e. if more than 50% of the epoch consisted of this EEG pattern). 
In addition, spindles were measured for frequency of occurrence 
according to the following criteria: the wave form should have a 
duration of at least 0.5 s, a frequency of 12-16 Hz and a peak 
amplitude of at least 20 gV. The sleep data of our patients were 
compared with normal values from the literature for age- and sex- 
matched controls [20, 24] which have been assembled by means of 
similar research procedures to our own. The data on females 
(20-29 years) reported by Williams et al. [24] were considered to 
be representative forhealthy female controls. 
The first night in the clinic was the adaptation night. The data 
of all other nights are presented. 
Resu l ts  
The diurnal blood pressure profile is reversed in these 
patients, so that they have the highest pressures early 
during the night and the lowest pressures early during 
day-time ambulat ion (Fig. 1). As a consequence, patients 
with chronic autonomic failure show the phenomenon 
known as "pressure-natriuresis",  which is responsible for 
patients waking up during the night when they have to 
void urine [10, 19]. 
No subjective sleep complaints were reported by 
either patient, although a general feeling of fatigue was 
present especially in the morning,  which is typical for 
patients with severe orthostatic hypotension.  Ear ly in 
the morning after rising frorn bed, blood pressure drop- 
ped to such a low level that it was not possible for the 
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Fig. 1. Diurnal blood pressure and heart rate patterns in two 
patients with dopamine beta-hydroxylase deficiency. Indicated are 
hourly averages of integrated mean arterial pressure. 0,  Patient 1; 
O, patient 2 ; . ,  diners, sitting in bed, followed by postprandial 
hypotension; V, left bed to void urine. Sleep period from 2200 to 
0700 hours. Note he reversal of the diurnal blood pressure 
rhythm, but the normal diurnal rhythm of heart rate 
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Table 2. Sleep parameters of all nights per patient. Control data of ten women (20-29 years) were obtained from Williams et al. [24] 
Sleep parameters Patient 1 Patient 2 Control 
Night Night ( 10 women) 
2 3 4 2 3 Mean SD 
Time in bed (min) 496.0 497.5 411.5 459.5 470.0 445.7 24.0 
Sleep period time (min) 460.0 436.5 390.5 453.5 468.0 432.3 22.0 
Total sleep time (min) 458.5 436.5 380.5 448.0 435.5 429.9 21.7 
Time awake (W) (min) 1.5 0.0 10.0 5.5 32.5 
Movement time (MT) (min) 3.5 1.5 5.0 6.0 5.0 
Sleep latency (min) 5.5 21.5 11.0 6.0 4.5 12.9 9.6 
Sleep efficiency index 0.92 0.88 0.92 0.97 0.93 0.96 0.02 
Minutes of stage 1 32.5 28.0 15.0 14.5 15.5 
2 145.5 128.5 66.5 151.5 154.5 
3 38.0 38.5 63.5 64.5 47.5 
4 112.5 95.0 85.5 86.0 71.5 
REM 76.0 83.0 71.5 90.5 105.0 
Alpha-delta 50.5 02.0 73.5 35.0 36.5 
% of stage W 0.3 0.0 2.6 1.2 6.9 0.5 0.5 
1 7.1 6.4 3.8 3.2 3.3 4.2 2.4 
2 31.6 29.4 17.0 33.4 33.0 52.4 5.9 
3 8.3 8.8 16.3 14.2 10.2 5.3 2.0 
4 24.5 21.8 21.9 18.9 15.3 12.4 6.2 
Slow wave sleep (3 + 4) 32.8 30.6 38.2 33.1 25.5 17.7 6.7 
REM 16.5 19.0 18.3 20.0 22.4 25.2 3.6 
Alpha-delta 11.0 14.2 18.8 7.7 7.8 
MT (/.8 0.3 1.3 1.3 1.1 
REM latency (min) 131.0 116.5 98.0 120.0 117.0 100.2 44.2 
Number of REM periods 3 4 4 5 5 4.2 0.9 
REM period length (min) Ä" 23.0 20.8 19.8 17.9 21.0 28.0 3.9 
SD 25.2 4.6 4.4 10.7 16.2 
NREM/REM cycle length (min) X 153.0 98.5 97.4 89.7 89.7 115.6 48.1 
SD 46.2 30.7 17.5 47.0 34.8 
patients to walk more than a few metres without sitting 
down (Fig. 1). Orthostatic hypotension made it impos- 
sible for the patients to participate in active physical 
activities. This was especially true for patient 1. Post- 
lunch naps occasionally occurred in patient 1, also dur- 
ing this study. These naps coincided with drops in blood 
pressure such as is normally observed shortly after meals 
in patients with chronic autonomic failure (Fig. 1). 
Sleep characteristics 
Sleep started soon after "lights out" in both patients; 
sleep latency was within normal limits (Table 2). Sleep 
was continuous and undisturbed for the whole sleep 
period in patient 1. Patient 2 woke up for a short period 
in one of the two nights, during which she needed to go 
to the toilet to void urine. After returning to bed, sleep 
was resumed almost instantly. Sleep stage percentages 
indicated the presence of a high percentage of slow-wave 
sleep (SWS) (stages 3 + 4) (patient 1: 34%; patient 2: 
29%), caused by an increased amount of both stage 3 
and stage 4 sleep. Healthy young adults are reported to 
spend + 20% of their sleep time in SWS [24] (Table 2). 
A relativety low to normal percentage of REM sleep 
(patient 1: 18%; patient 2: 21%) was observed, com- 
pared with the 25% of REM steep normally found in 
young adults [24]. REM latency was within normal 
limits, as was the cyclic occurrence of the REM periods 
(Fig. 2). The occurrence of alpha-delta sleep (Fig. 3) was 
more explicit in patient 1 than in patient 2: 15% and 8%. 
The alpha rhythms were in the 7-10 Hz range; thus, they 
were somewhat slower than waking alpha and were con- 
centrated in the first half of the sleep period. The pres- 
ence of an increased amount of SWS and the separate 
quantification of alpha-delta sleep resulted in a reduced 
amount of stage 2 sleep. Even if we added the time spent 
in  alpha-delta sleep to that spent in stage 2 sleep, stage 2 
sleep still remained 10% below normal values. 
In patient 1, some light snoring occurred during vari- 
ous parts of the nights, but no relation was established 
between snoring and the presence of alpha-delta sleep or 
any other sleep stage. Alpha-delta sleep was accom- 
panied by a reduced amount of spindles in patient 1: the 
total number of spindles per night varied between 7 and 
13. The total number of spindles per night in patient 2 
was 412 and 634. 
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Fig. 2. Hypnogram of a sleep 
recording of patient 1. Y-axis: -1, 
stage REM; 0, awake; 1-4, stages 
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Fig. 3. Alpha-delta sleep as it 
occurred in frontal, central and 
occipital EEG leads 
Discuss ion  
In these patients with a selective central and peripheral 
noradrenaline deficit as a result of congenital DBH defi- 
ciency, a number of sleep characteristics were remark- 
able: 
1. No subjective sleep complaints were reported; sleep 
was continuous and almost never interrupted by inter- 
mittent awakenings, except when the patients awakened 
to void urine due to "pressure-natriuresis'. 
2. The percentage of REM sleep was somewhat lower 
than normal. However, this abnormality was quantita- 
tively certainly not large enough to impty an abnormal 
REM sleep pattern in these patients. In addition, a nor- 
mal ultradian cyclicity in REM periods was observed. 
3. In relation to a reduced amount of stage 2 sleep, a 
large amount of SWS was observed in both patients, in 
spite of the fact that naps occurred during day-time. In 
healthy subjects, naps have been shown to have a nega- 
tive influence on the occurrence of SWS during the fol- 
lowing sleep period [8]. 
4. The presence of alpha-delta sleep was more explicit in 
patient 1 than in patient 2. 
Alpha-delta sleep in our patients partly consisted of the 
intrusion of the EEG alpha frequency into NREM sleep, 
as has been reported in psychiatric disorders [6], fibro- 
myositis [15], and disorders of excessive somnolence [4]. 
However, the major part of the alpha-delta sleep pattern 
that we observed consisted of alternating patterns of reg- 
ular alpha sleep with delta bursts, somewhat similar to 
the "micro-arousals" described by Lavie et al. [9], al- 
though this pattern did not present itself as short-lasting 
arousals but as continuous periods which could last for 
several minutes. The alpha-delta sleep pattern has been 
associated with complaints of non-restorative sleep [15] 
and suggests the presence of an arousal-related disorder, 
such as nocturnal myoclonus or teep apnoea syndrome. 
We observed no clinical indication for the presence of 
either in our patients. The reduced amount of spindles in 
patient 1 corresponds with the findings of Hauri and 
Hawkins [6] where it concerns the lack of spindles during 
alpha-delta sleep. The number of spindles per night in 
patient 2 was not different from the data of healthy sub- 
jects reported by Silverstein and Levy [21]. 
Noradrenaline and REM sleep 
Data with regard to the role of mono-aminergic neuro- 
transmitters in sleep-wake regulatory mechanisms in 
man are usually based on the responses to agonist and 
antagonist drugs. Wakefulness and REM sleep are 
frequently coupled with increased and decreased nor- 
adrenergic activity, respectively [5]. A positive relation 
has been described with wakefulness, but the specific 
noradrenergic role in the initiation or production of 
REM sleep is more complex. Electrophysiological stud- 
ies indicated that noradrenergic activity is involved in 
the slowing and cessation of REM-off cell discharge (in 
the locus ceruleus) before and during REM sleep, there- 
by emphasizing the inhibitory role of noradrenaline in
the production of REM sleep [7, 18]. Gaillard [5] sug- 
gested that some noradrenergic neurons in the brain 
stem (locus ceruleus) are active when the subject is 
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awake and si lent dur ing REM sleep, and this by itself 
forms a prerequis i te for REM sleep to appear.  A t  the 
same t ime, the activity of other  noradrenerg ic  neurons 
(in midbra in ,  pons or subceruleus area) is necessary for 
the occurrence of REM sleep. 
Our  data indicate that noradrenal ine  is not essential 
for wakefulness during day-t ime,  nor for the init iation, 
cyclicity and maintenance of (REM)  sleep phenomena,  
a l though some alterat ions in durat ion of SWS, stage 2 
and REM sleep do occur. These data favour the hypo- 
thesis of a noradrenerg ic  modulatory  role in (REM)  
s leep-generat ing mechanisms.  
Dopamine and sleep 
With  regard to the central  role of dopamine,  it is be- 
l ieved that this neurotransmit ter  is pr imar i ly  involved in 
behavioura l  arousal.  In mammals ,  dose-re lated biphasic 
effects to dopamine  agonist and antagonist  drugs during 
sleep have been descr ibed [22]. In man, apomorph ine  
caused a strong suppressant effect on SWS and REM 
sleep and increased stage 2 sleep [2]. In addit ion,  it had 
sedative and s leep- inducing propert ies  in normal  and 
schizophrenic subjects [3]. Other  studies with dopamine 
antagonists suggest a minimal  role for dopamine in sleep 
[17]. 
The data of our pat ients contradict  the SWS findings, 
but are to some extent in agreement  with the REM sleep 
findings, since our pat ients showed a (slightly) reduced 
amount  of REM sleep. It is possible that the excess of 
dopamine  is active on dopaminerg ic  receptors on nor- 
adrenergic  neurons in the brain or that it exerts an action 
on alpha- and beta-adrenerg ic  receptors,  especial ly in 
the light of the denervat ion supersensit iv ity which can be 
demonst ra ted  in these patients [12]. Since administra-  
t ion of alpha- and beta -adrenoceptor  antagonists had no 
haemodynamic  effects in our pat ients [11, 13], it is ex- 
t remely  unl ikely that the increased concentrat ions of 
dopamine  exerted actions on (central)  adrenergic recep- 
tors. This hypothesis  can be further tested by studying 
the effects of a dopamine  antagonist  and/or  noradrena-  
line rep lacement  therapy [12] on the sleep patterns of 
our patients.  
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